[Effects of glucuronyl-glucosamino-glycan sulfate in a group of patients with blood lipid disorders].
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000097:blood; D001161:Arteriosclerosis / Q000097:blood; D002561:Cerebrovascular Disorders / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D005965:Glucuronates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D006973:Hypertension / Q000097:blood; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood*
D005965:Glucuronates; D006025:Glycosaminoglycans; D014280:Triglycerides
Osservazioni sull'attività del glucuronil-glucosamin-glicano-solfato in un gruppo di pazienti dislipidemici.